CLINICAL_TRIALS
trial_result
· 2019-07-31
Clinical Trial Update: A Study to Evaluate Albumin and Immunoglobulin in Alzheimer's Disease [Phase 2, Phase 3]
Summary
Phase 2/3 trial evaluating albumin and immunoglobulin in Alzheimer's disease has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Instituto Grifols, S.A. | Conditions: Alzheimer's Disease | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2019-07-31